コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 1 and MprF2) found in the bacterial pathogen Clostridium perfringens.
2 oss firmicutes, including the human pathogen Clostridium perfringens.
3 Escherichia coli, Bacteroides fragilis, and Clostridium perfringens.
4 ccus aureus, Clostridium acetobutylicum, and Clostridium perfringens.
5 tory activity for a bacterial NEU, NanI from Clostridium perfringens.
6 typical cholesterol-dependent cytolysin from Clostridium perfringens.
7 e(s) have been validated for this purpose in Clostridium perfringens.
8 of Clostridium botulinum, and iota toxin of Clostridium perfringens.
9 of Clostridium septicum and epsilon-toxin of Clostridium perfringens.
10 AlgR of Pseudomonas aeruginosa, and VirR of Clostridium perfringens.
11 on toxin secreted by the anaerobic bacterium Clostridium perfringens.
12 nization of specific-pathogen-free chicks by Clostridium perfringens.
13 cherichia coli, 50% GC; calf thymus, 42% GC; Clostridium perfringens, 27% GC) have been employed as t
14 ism isolated from dogs, cats, and horses was Clostridium perfringens (75, 13, and101 isolates, respec
17 cross-react with a homologous sequence of a Clostridium perfringens adenosine triphosphate-binding c
18 idues with 90% homology to a sequence within Clostridium perfringens adenosine triphosphate-binding c
19 be immediate and direct, as in the action of Clostridium perfringens alpha toxin on red cells or plat
27 obacterium hafniense, Clostridium novyi, and Clostridium perfringens and increase their activity up t
28 ization and replication of bacteria, such as Clostridium perfringens and Salmonella enterica serovar
29 for all corresponding genes of 26 strains of Clostridium perfringens and Streptococcus pneumoniae.
30 erences between the germination of spores of Clostridium perfringens and that of spores of a number o
31 H gene, encoding a hyaluronidase secreted by Clostridium perfringens, and a C. perfringens hyaluronid
33 with enterobacteria, desulfovibrios, type E Clostridium perfringens, and Enterococcus faecalis, wher
34 ric AIPs from Lactiplantibacillus plantarum, Clostridium perfringens, and Listeria monocytogenes that
35 odborne outbreaks caused by Bacillus cereus, Clostridium perfringens, and Staphylococcus aureus were
37 e anaerobic sulfatase-maturating enzyme from Clostridium perfringens (anSMEcpe) catalyzes the two-ele
39 s of the common human and livestock pathogen Clostridium perfringens are attributable to a formidable
40 gglutinin upon digestion with sialidase from Clostridium perfringens, Arthrobacter neurofaciens, or S
41 olysin perfringolysin O (PFO) is secreted by Clostridium perfringens as a bacterial virulence factor
42 o-beta-galactosidase designated E-ABase from Clostridium perfringens ATCC 10543 capable of liberating
43 mercially available sialidases prepared from Clostridium perfringens ATCC10543 were contaminated with
47 h potent activity against the human pathogen Clostridium perfringens By combining in vivo and in vitr
50 ubnetworks associated with responses against Clostridium perfringens, Candida albicans, and Bacteroid
51 -beta-galactosidase (Endo-beta-Gal(GnGa)) in Clostridium perfringens capable of releasing GlcNAcalpha
55 rtex by cortex-lytic enzymes (CLEs), and two Clostridium perfringens CLEs, SleC and SleM, degrade cor
56 tridia in Cluster I, including the pathogens Clostridium perfringens, Clostridium botulinum and Clost
57 y Bacillus anthracis, Staphylococcus aureus, Clostridium perfringens, Clostridium botulinum, and Clos
58 tigated a putative cell-surface adhesin from Clostridium perfringens comprising an N-terminal adhesin
60 P = .1 and P = .01 for consecutive samples); Clostridium perfringens continued to be more prevalent i
61 against pathogenic bacterial sialidases from Clostridium perfringens (CpNanI) and Vibrio cholerae.
62 c properties against human pathogens such as Clostridium perfringens, define two hairpin domains givi
69 ious epidemiological studies have implicated Clostridium perfringens enterotoxin (CPE) as a virulence
83 d the potential superantigenic properties of Clostridium perfringens enterotoxin (CPE) on human perip
85 ost in vitro studies exploring the action of Clostridium perfringens enterotoxin (CPE) utilize either
86 ies performed to investigate the topology of Clostridium perfringens enterotoxin (CPE) when this toxi
88 relationship and mechanism of action of the Clostridium perfringens enterotoxin (CPE), a series of r
90 -affinity intestinal epithelial receptor for Clostridium perfringens enterotoxin (CPE), and is suffic
91 y receptors, respectively, for the cytotoxic Clostridium perfringens enterotoxin (CPE), in this study
97 the localization of the genes for the CPE-R (Clostridium perfringens enterotoxin receptor, CPETR1) an
99 for the sporulation-associated synthesis of Clostridium perfringens enterotoxin, a common cause of f
100 xins, such as botulinum neurotoxins (BoNTs), Clostridium perfringens epsilon toxin (ETX), staphylococ
102 the motion of single membrane receptors, the Clostridium perfringens epsilon-toxin (CPepsilonT) recep
105 d (Staphylococcus aureus, Bacillus subtilis, Clostridium perfringens, Escherichia coli), except Enter
106 ntestinal inhabitants: Bacteroides fragilis, Clostridium perfringens, Escherichia coli, Klebsiella pn
107 ia (FIBs; Escherichia coli, enterococci, and Clostridium perfringens) exhibited biphasic decay patter
117 PFO, a virulence factor of the organism Clostridium perfringens, has almost the same molecular m
118 ly, the genome sequences of three strains of Clostridium perfringens have been completed and we ident
120 robiology methods are not suitable to detect Clostridium perfringens in formalin-fixed, paraffin-embe
138 turnoff assay for phospholipase C (PLC) from Clostridium perfringens is developed based on the revers
146 potent pore forming toxin (PFT) produced by Clostridium perfringens, is responsible for the pathogen
147 logical studies suggested that cpb2-positive Clostridium perfringens isolates are associated with gas
148 s such as norovirus and toxigenic strains of Clostridium perfringens, Klebsiella oxytoca, Staphylococ
149 his model is challenged by the glycosylating Clostridium perfringens large cytotoxin (TpeL toxin) tha
150 and in vitro activity on human substrates of Clostridium perfringens NagJ, a close homologue of human
152 ysis, we were able to identify inhibitors of Clostridium perfringens neuraminidase present in a root
154 omic sequences, but only in three bacterial (Clostridium perfringens, Oenococcus oeni, and Leuconosto
155 e monomeric cytolysin secreted by pathogenic Clostridium perfringens, oligomerizes and forms large po
156 ontrast, perfringolysin O (PFO), secreted by Clostridium perfringens, only binds to membranes contain
159 S. pyogenes gene that closely resembles the Clostridium perfringens pfoR gene, exerts a negative eff
161 ws 60% amino acid sequence identity with the Clostridium perfringens phospholipase C, or alpha-toxin
167 ssociated O-acetyl sialic acid--but not from Clostridium perfringens resulted in an increase in RN639
169 e crystal structure of ligand-free NanE from Clostridium perfringens reveals a modified triose-phosph
170 pathogenesis, application of the approach to Clostridium perfringens reveals heterogeneous expression
171 reduced disease-associated bacteria such as Clostridium perfringens, Ruminococcus gnavus, and Klebsi
179 ess and purify a representative chimera from Clostridium perfringens (termed CperHydR) and apply vari
180 2-aminobenzoic acid using neuraminidase from Clostridium perfringens that cleaves sialic acid monomer
181 peL is a recently identified LCT produced by Clostridium perfringens that has received relatively lim
185 initially attributed to norovirus; however, Clostridium perfringens toxicoinfection was subsequently
204 usative organism of enteritis necroticans is Clostridium perfringens type C, an anaerobic gram-positi
211 silon-toxin, the primary virulence factor of Clostridium perfringens type D, causes mortality in live
213 iota toxin, a binary enterotoxin produced by Clostridium perfringens type E, were studied by fluoresc
214 ration-initiated hydrolysis catalyzed by the Clostridium perfringens unsaturated glucuronyl hydrolase
215 and in the pathogenesis of cystic fibrosis; Clostridium perfringens VirR, a regulator of virulence f
218 ogens using virulence factors as indicators; Clostridium perfringens was revealed as a likely pathoge
219 4 mo, counts of Clostridioides difficile and Clostridium perfringens were ~90% (P < 0.001) and ~65% (
220 ignificant increases in genus Sutterella and Clostridium perfringens when compared to healthy dogs.